Dynamic expression of CD9 protein in T-cell acute lymphoblastic leukemia.
The study reports heterogeneous CD9 expression in T-ALL, with enrichment in the TAL1-positive subtype, a tendency to increase at relapse, and associations with leukemic-cell migration and extracellular-vesicle biogenesis in mouse and human translational analyses.
Open original publication →What the AI sees
The study reports heterogeneous CD9 expression in T-ALL, with enrichment in the TAL1-positive subtype, a tendency to increase at relapse, and associations with leukemic-cell migration and extracellular-vesicle biogenesis in mouse and human translational analyses.
Research significance
The supplied evidence links CD9 to migration, peripheral tissue involvement, extracellular-vesicle biogenesis, and relapse-associated T-ALL; it is therefore reasonable—but still inferential—to hypothesize that CD9 could serve as a relapse-risk biomarker or therapeutic target, pending causal perturbation studies and prospective human validation.
Source abstract
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy affecting both children and adults. Given its persistently poor prognosis, there is a critical need to identify additional factors involved in T-ALL oncogenesis and progression. CD9, a membrane protein of the tetraspanin family implicated in diverse cellular processes, has been associated with prognosis in several cancers, yet its role in T-ALL remains poorly understood. In this study, using a mouse model first, we found that CD9 overexpression is associated with leukemic T cells that have migrated outside the thymus into peripheral tissues. Then, analysis of a human T-ALL cohort shows that CD9 expression is heterogeneous, tends to increase at relapse and is enriched in the TAL1⁺ molecular subtype. We further demonstrate that CD9⁺ cells display enhanced migratory capacity compared with CD9⁻ counterparts, and that CD9 levels affect extracellular vesicle biogenesis. Altogether, our findings support a role for CD9 in T-ALL leukemogenesis and highlight its potential involvement in relapse.